Ronald J. Daniels
CIK: 0001164475
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (25.0%)
Position reduction
Option Exercises (M)1 (25.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BBIO
BridgeBio Pharma, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 22, 2026BBIO
BridgeBio Pharma, Inc.
Award(A)Direct4K shares- - Nov 6, 2025BBIO
BridgeBio Pharma, Inc.
Exercise(M)Direct61K shares at avg. $34.65$2.1M - Nov 6, 2025BBIO
BridgeBio Pharma, Inc.
Sale(S)Direct61K shares at avg. $63.72$3.9M - Jun 20, 2025BBIO
BridgeBio Pharma, Inc.
Award(A)Direct6.6K shares-
1-4 of 4 transactions
About DANIELS RONALD J
DANIELS RONALD J (SEC CIK 0001164475) files insider reports with the SEC as Director of BridgeBio Pharma, Inc. (BBIO).
Signal8 holds 3 ownership filings by DANIELS RONALD J, all Form 4s, filed between Jun 24, 2025 and Jun 24, 2026. Those filings report 4 transactions, from Jun 20, 2025 to Jun 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on DANIELS RONALD J's filings is in PALO ALTO, CA.
Recent filings by DANIELS RONALD J
Other insiders filing for BridgeBio Pharma, Inc. (BBIO)
- Apuli Maricel, Chief Accounting Officer
- Kumar Neil, Chief Executive Officer
- Trimarchi Thomas, President and CFO
- Ellis Andrea, Director
- Cook Jennifer E., Director
- Valantine Hannah, Director